VIATRIS INC. Restructuring Reserve
VIATRIS INC. (VTRS) had Restructuring Reserve of $60.80 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-08-06
- 2026-06-30: Restructuring Reserve $60.80M.
- 2026-03-31: Restructuring Reserve $69.80M.
- 2025-12-31: Restructuring Reserve $0.00.
- 2023-09-30: Restructuring Reserve $98.30M.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2026-06-30 | $60.80M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $69.80M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-06 | |
| 2023-09-30 | $98.30M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $108.70M 10-Q · filed 2023-11-08 | |
| 2023-03-31 | $136.10M 10-Q · filed 2023-11-08 | |
| 2022-12-31 | $157.50M 10-Q · filed 2023-11-08 | |
| 2022-09-30 | $159.10M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $186.30M 10-Q · filed 2022-11-07 | |
| 2022-03-31 | $223.30M 10-Q · filed 2022-11-07 | |
| 2021-12-31 | $22.80M 10-K · filed 2023-02-27 | $296.70M 10-Q · filed 2022-05-09 |
| 2021-09-30 | $370.60M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $498.70M 10-Q · filed 2021-11-08 | |
| 2021-03-31 | $376.50M 10-Q · filed 2021-11-08 | |
| 2020-12-31 | $29.20M 10-K · filed 2023-02-27 | $22.80M 10-K · filed 2021-03-01 |
| 2019-12-31 | $29.20M 10-K · filed 2022-02-28 | |
| 2018-12-31 | $72.60M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |